Skip GNB
Skip Content
About Us
Company
Our DNA
Samsung Biologics Way
Fact Sheet
Milestones
Leadership
Key Executives
CEO Message
Location
Headquarters
- Bio Campus I
- Bio Campus II : Plant 5
Samsung Biologics America
Useful Pages
Facilities - 360° Tour
Our Services
Development Services
Overview
Late Discovery
Cell Line Development
Process Development
Analytical Development
Non-GMP / CGMP Manufacturing
Manufacturing Services
Overview
Drug Substance
Drug Product
Quality Services
Overview
Quality Assurance
Quality Control
Analytical Testing Services
New Modalities
Antibody-Drug Conjugates
mRNA
Careers
Our Values
Working With Us
Career Development
Benefits
Diversity & Inclusion
How to Apply
Application Process
OverseasExperienced
LocalExperienced
NewHiresULevel
NewHiresCLevel
Intern
FAQs
Job Information
Sustainability
ESG Management
Our Commitment
Resources
Environmental
Climate Actions
SHE Management
Environment
Safety
Health
Social
Human Rights
Compliance
Business Ethics
Corporate Social Responsibility
Suppliers
BCMS
Governance
Articles of Incorporation
Board Structure
BOD Committees
Corporate Governance
External Auditor
Investors
Overview
Financial Information
Financial Snapshot
Financial Report
- Financial Statements
- Business Report
- Earnings Release
Stock & Shareholder
Information
Listing Information
Stock Charts
Ownership Structure
General Meeting of Shareholders
IR Resource
Public Disclosures
IR Notice
Newsroom
Newsroom
Company News
Press Release
News Brief
Media Focus
Our Story
Life @ Samsung Biologics
Samsung Bio Insight
Science & Technology
Whitepapers
Posters
Webinars
PR Materials
Brochures & Infographics
Company Images
Videos
Events
KOR
ENG
Selectd
search
NEWSFEED
Contact Us
mobile menu button
Search Close
Enter a search term
home
CONTACT US
IR Notice
Newsletter
2021 FY CEO IR Newsletter
January 24, 2022
LINKEDIN
FACEBOOK